Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study

Fernando C Wehrmeister (Pelotas, Brazil), Fernando C. Wehrmeister, Ana Maria B. Menezes, Maria Montes de Oca, Carlos Tálamo, Maria Victorina Lopez-Varela, Adriana Muiño, Gonzalo Valdivia, Carmem Lisboa, Jose R. Jardim, Rogelio Perez-Padilla

Source: International Congress 2015 – Prevalence of respiratory disease
Session: Prevalence of respiratory disease
Session type: Thematic Poster Session
Number: 1125
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fernando C Wehrmeister (Pelotas, Brazil), Fernando C. Wehrmeister, Ana Maria B. Menezes, Maria Montes de Oca, Carlos Tálamo, Maria Victorina Lopez-Varela, Adriana Muiño, Gonzalo Valdivia, Carmem Lisboa, Jose R. Jardim, Rogelio Perez-Padilla. Inequalities on medical diagnosis and underdiagnosis of COPD: The PLATINO study. Eur Respir J 2015; 46: Suppl. 59, 1125

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Heterogeneity in prevalence and underdiagnosis of COPD: Results from BOLD, EPI-SCAN, PLATINO, and PREPOCOL
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013

Prevalence and incidence of COPD: The Rotterdam study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Co-morbidities of COPD in primary care
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015

Comorbidities and burden of COPD: A population based case-control study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013


Defining asthma COPD overlap syndrome (ACOS): A population based study
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


COPD morbidity screening in high risk groups
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study
Source: International Congress 2014 – Highlights in respiratory epidemiology
Year: 2014


COPD prevalence in Argentina: The EPOC.AR study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

Comorbidities and COPD severity: The French Palomb cohort
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Mortality rates in individuals with asthma, COPD and ACOS in a large population-based cohort: Is gender important?
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016


Productivity losses in COPD – A population-based survey.
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014

Disease burden in COPD patients in the first 24 months following diagnosis in a UK primary care setting
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Comorbidities, gender-differences and COPD severity: The French Palomb cohort
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Unemployment in COPD: Results from the BOLD study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

Comorbidity in patients with IHD - the prevalence of COPD
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016

COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Use of medicines and prevalence of co-morbid diseases in subjects with and without COPD in Sweden
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013

Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015



Predicting risk of undiagnosed COPD in primary care: Development and validation of the TargetCOPD model
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016